DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for Soft Tissue Chondroma — screening already-approved drugs against its 2-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleSoft Tissue Chondroma maps to a 2-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for soft tissue chondroma is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
Soft tissue chondroma is a rare benign cartilaginous tumour that grows slowly and is most often found in the hands and feet. A 2000 study notes that when it arises from soft tissues rather than bone it is called extraskeletal chondroma, and that the most common presentation is a slow-growing, firm, painless, and occasionally tender mass. Morphologically the tumour shows lobular structures of hyaline cartilage, which makes it difficult to differentiate from low-grade chondrosarcoma. Immunohistochemistry is the cornerstone for definite diagnosis: S100 protein and vimentin are positive in tumour cells and the proliferation index (Ki67%) is low. Recurrence is possible if the tumour is incompletely removed, so complete removal with the capsule is required.
A 2001 case report describes a 54-year-old man with a 6 x 5-cm swelling on his right forearm that had been present for 20 years. Fine needle aspiration cytology showed myxofibrillary material and pleomorphic cells. The authors conclude that the clinical, radiologic and cytologic triad is important for correct cytologic diagnosis despite worrisome cell atypia. A 2016 case report notes that scrotal chondroma is exceedingly rare, with only a few cases reported worldwide, and that it should be differentiated from well-differentiated chondrosarcoma. A 2022 report of two periarticular soft tissue chondromas around the knee and shoulder states that the periarticular location and non-specific radiographic findings can cause serious diagnostic difficulties.
No drug treatment is mentioned in any of these abstracts. The evidence is limited to case reports and small case series, with no controlled trials, no data on systemic therapy, and no information on patient stratification. What is missing is any prospective study design, any investigation of molecular markers beyond S100 and Ki67, and any funding for a trial that could test a drug in this rare tumour.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Acta Cytologica · 2001 · 11 citations
Fine Needle Aspiration Cytology of Soft Tissue Chondroma
AbstractBACKGROUND: Soft tissue chondroma, though rare, is well known to histopathologists and radiologists. Cytologic features of soft tissue chondroma mimic those of its malignant counterpart to a considerable extent. To our knowledge, this is the first case in which the aspiration cytology of soft tissue chondroma is described as an aid to definitive diagnosis. CASE: A 54-year-old male presented with a 6 x 5-cm swelling on his right forearm that had existed for 20 years. Its extraskeletal location was confirmed. Aspiration cytology showed myxofibrillary material and pleomorphic cells. CONCLUSION: The clinical, radiologic and cytologic triad is important for the correct cytologic diagnosis of soft tissue chondroma despite worrisome cell atypia.
Indian Journal of Pathology and Microbiology · 2016 · 3 citations · open access
Scrotal chondroma in a young male: A rare case report
AbstractSoft tissue chondroma is a rare benign, slow growing tumor usually located in hand and foot. Scrotal chondroma is exceedingly rare; chondromas in the pelvic region have also been reported. However, chondroma occurring in the scrotal wall is extremely rare, and only a few cases have been reported worldwide. They should be differentiated from well-differentiated chondrosarcoma. To the best of our knowledge, this is the first case of scrotal chondroma to be reported from India.
AbstractThe term chondroma refers to a slow-growing benign tumor. When the tumor arises from the medullary cavity, it is referred to as enchondroma, which is a very common bone tumor. However, if it arises from soft tissues, which is extremely rare, it is referred to as soft tissue chondroma or extraskeletal chondroma. Extraskeletal chondromas are uncommon; benign soft tissue tumors that mostly originate from hyaline cartilage are unrelated to the periosteum, tendon, or bone. The most common sites include fingers and toes. The frequent presentation is a slow-growing, firm, painless, and occasionally tender soft tissue mass. Morphologically, it exhibits lobular structures of hyaline cartilage, and hence it becomes difficult to differentiate it from low-grade chondrosarcoma, so the alarming sign of differentiation becomes a must. Recurrence is possible if it is incompletely removed. Complete removal with the capsule is a must to avoid recurrence. Immunohistochemistry remains the cornerstone for a definite diagnosis when S100 protein and vimentin show positivity for tumor cells and the proliferation index (Ki67%) is low. In this study, we present a very uncommon case of a 30-year-old patient with soft tissue chondromatosis of the palmer aspect of the index finger and palm.
THE JOURNAL OF THE BULGARIAN ORTHOPAEDICS AND TRAUMA ASSOCIATION · 2022 · 0 citations · open access
Periarticular soft tissue chondroma around the knee and shoulder joint – report of 2 cases
AbstractSoft tissue chondroma is a rare benign cartilaginous tumor with a typical localization in the hands and feet. The periarticular development of the tumor, combined with its non-specific radiographic manifestation, can lead to serious diagnostic difficulties. We present 2 clinical cases of periarticular soft tissue chondroma, diagnosed and treated in our clinic within the last 2 months.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
